Adam S. Grossman
2020
In 2020, Adam S. Grossman earned a total compensation of $2M as Director, President and Chief Executive Officer at ADMA Biologics, a 15% increase compared to previous year.
Compensation breakdown
Bonus | $486,000 |
---|---|
Option Awards | $544,517 |
Salary | $600,000 |
Stock Awards | $291,500 |
Other | $40,124 |
Total | $1,962,141 |
Grossman received $600K in salary, accounting for 31% of the total pay in 2020.
Grossman also received $486K in bonus, $544.5K in option awards, $291.5K in stock awards and $40.1K in other compensation.
Rankings
In 2020, Adam S. Grossman's compensation ranked 5,604th out of 13,090 executives tracked by ExecPay. In other words, Grossman earned more than 57.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,604 | 57th |
Manufacturing | 2,313 | 59th |
Chemicals And Allied Products | 923 | 59th |
Drugs | 798 | 59th |
Biological Products, Except Diagnostic Substances | 194 | 53rd |
Grossman's colleagues
We found two more compensation records of executives who worked with Adam S. Grossman at ADMA Biologics in 2020.
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019